You are here

Article Text

Article menu
Download PDFPDF
Letter
Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
  1. M Yoneda1,2,
  2. K Fujita1,
  3. M Inamori1,
  4. A Nakajima1,
  5. M Tamano2,
  6. H Hiraishi2
  1. 1Division of Gastroenterology, Yokohama City University Hospital, Yokohama, Japan
  2. 2Department of Gastroenterology, Dokkyo Medical University, Tochigi, Japan
  1. Correspondence to:
    Dr Atushi Nakajima
    Division of Gastroenterology, Yokohama City University Hospital, 3–9 Fuku-ura, Kanazawa-ku, Yokohama 236-0004, Japan; nakajima-tky{at}umin.ac.jp

https://doi.org/10.1136/gut.2007.126417

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury in many countries around the world.1 NAFLD covers a wide spectrum, ranging from simple steatosis—which is generally non-progressive—to non-alcoholic steatohepatitis (NASH). There are no established non-invasive methods of evaluation for patients with NASH, and until recently liver biopsy was the only method for evaluating liver fibrosis. Transient elastography is a new technique that allows rapid, non-invasive measurement of mean tissue stiffness, which has been shown to be useful for accurate estimation of hepatic fibrosis in patients with chronic hepatitis C.2

    We carried out a study to determine the value of liver stiffness measurement with the new medical device called the …

    View Full Text

    Footnotes

    • Conflict of interest: None declared.